Merck & Co has made another move towards diversifying its pipeline and reducing its reliance on blockbuster cancer drug Keytruda, pledging $525 million to an alliance with Synthekine initially ...
Abstract: Inspired by the combination of zero-sum game and fixed-time convergence, this study investigates the optimal control strategy for a multisatellite fixed-time pursuit–evasion zero-sum game. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback